104 web-programmer-developer-"https:"-"https:" positions at City of Hope in United States
Sort by
Refine Your Search
-
for collecting and handling specimens; ensure proper labeling and obtain pertinent clinical and protocol information on request forms; develop and maintain knowledge of various aspects of processing specimens
-
successful candidate, you will be: Developing liquid biopsy biomarkers for cancer diagnosis, prognosis, and therapy response prediction. Investigating the epigenetic basis of GI cancers, such as aberrant DNA
-
modify protocols. Write standard operating procedures and reports. Maintain records of work performed, including results and methodology; utilizing records may calculate, graph, and compile data. Develop
-
. · Perform comprehensive molecular validation and phenotyping techniques. · Support manuscript development, figure design, and integration of interim research findings to drive research progress. Your
-
hematopoiesis, leukemogenesis, and tumorigenesis as well as developing new targeted therapies for hematological malignant diseases and cancers. Our research involves experiments with various biochemistry and
-
of Hope. This role offers an exciting opportunity to investigate immune checkpoint signaling within the tumor microenvironment and contribute to the development of novel anticancer therapies
-
the Department of Immuno-Oncology focuses on how blood and immune cells develop, function, and interact with other cells, with a second focus on how blood stem cells become malignant. We use mass spectrometry
-
; contributing to manuscripts and grant applications; and assembling reports and presentations. Keep detailed and accurate logs of experimental design and primary data, analysis, and synthesis. Prepare data
-
drive our multiomics, high-throughput sequencing projects and help develop any projects based on the most advanced technologies. Your qualifications should include: Ph.D. in Biochemistry, Bioinformatics
-
of adipose tissue and its link to age-related metabolic disorders and cancer. Ultimately, we aim to mitigate the pathogenesis and develop treatments for chronic metabolic diseases. We have established unique